Bristol-Myers Squibb - Top 13 Ad Budgets

Company: Bristol-Myers Squibb bms.png
2007 Ad Spending: $796.3 million
2006 Ad Spending: $690.6 million

Breakdown

  • Magazines: $158.3 million
  • Newspaper: $6.8 million
  • Outdoor: $1 million
  • TV: $201.4 million
  • Radio: $200,000
  • Internet: $7.8 million

Where BMS is spending money: By far, BMS spent the most money on advertising Plavix ($174.8 million), the company's blockbuster anti-clotting drug, which was up 16.7 percent from 2007. Spending on company image advertising ($51M) and and the recently-approved rheumatoid arthritis drug Orencia ($35M) rounded out BMS's top campaigns.

The company focused on a key media area in 2007. Television ad spending was up in all categories: network TV (11.8 percent) spot TV (320 percent), syndicated TV (48 percent) and network TV (206 percent). In addition, B-to-B magazine ad spending was up 863 percent. BMS's ad budget grew 15.3 percent in total, and sales were up 12 percent to $19.3 billion.

Where BMS isn't spending money: The ad budget for psychiatric drug Abilify was down slightly from $101 million to $98 million. And the money that BMS dedicated to television commercials was taken from newspaper, radio and internet advertising budgets, all of which fell in 2007.

Bristol-Myers Squibb - Top 13 Ad Budgets
Read more on

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.